Xiao-Han Chen Selected Research

NPS 1506

9/2004

Acute treatment with MgSO4 attenuates long-term hippocampal tissue loss after brain trauma in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao-Han Chen Research Topics

Disease

11	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2009 - 12/2002
6	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2002
3	Brain Injuries (Brain Injury) 09/2004 - 12/2002
3	Wounds and Injuries (Trauma) 08/2004 - 12/2002
2	Paralysis (Palsy) 06/2022 - 01/2022
2	Ischemic Stroke 01/2020 - 04/2010
2	Stroke (Strokes) 08/2009 - 09/2006
2	Hemorrhage 04/2008 - 09/2006
2	Demyelinating Diseases (Demyelinating Disease) 11/2004 - 12/2002
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2004 - 12/2002
1	Hypoxia (Hypoxemia) 04/2020
1	Disease Progression 01/2020
1	Cognitive Dysfunction 01/2020
1	Coronary Disease (Coronary Heart Disease) 07/2017
1	Hypertension (High Blood Pressure) 07/2017
1	Parkinson Disease (Parkinson's Disease) 02/2017
1	Unconsciousness (Loss of Consciousness) 09/2011
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2010
1	Thrombosis (Thrombus) 09/2009
1	Ischemia 07/2008
1	Nerve Degeneration 04/2008
1	Contusions 04/2008
1	Cerebral Hemorrhage 04/2008
1	Brain Contusion 04/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2007
1	Synucleinopathies 12/2007
1	Infarction (Infarctions) 09/2006
1	Brain Edema (Cerebral Edema) 09/2006
1	Necrosis 03/2004

Drug/Important Bio-Agent (IBA)

5	Amyloid beta-PeptidesIBA 04/2009 - 12/2002
4	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2010 - 09/2006
2	Neuroprotective AgentsIBA 02/2017 - 04/2008
2	Proteins (Proteins, Gene)FDA Link 12/2007 - 12/2002
2	Apolipoproteins E (ApoE)IBA 10/2005 - 10/2005
2	Interleukin-12 (IL 12)IBA 11/2004 - 12/2002
2	PlacebosIBA 07/2003 - 12/2002
1	DiterpenesIBA 06/2022
1	Biological ProductsIBA 01/2022
1	NitritesIBA 04/2020
1	cadinaneIBA 04/2020
1	SesquiterpenesIBA 04/2020
1	Thyroid HormonesIBA 01/2020
1	Amyloidogenic ProteinsIBA 01/2020
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 07/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2017
1	icariinIBA 02/2017
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2017
1	antineoplaston A10 (A 10)IBA 09/2011
1	Immunoglobulin G (IgG)IBA 09/2009
1	Hemostatics (Antihemorrhagics)IBA 04/2008
1	Factor VIIa (Activated Factor VII)IBA 04/2008
1	recombinant FVIIa (rFVIIa)FDA Link 04/2008
1	Plasminogen InactivatorsIBA 09/2006
1	Amino Acids FDA Link 09/2006
1	ClusterinIBA 10/2005
1	ApolipoproteinsIBA 10/2005
1	NPS 1506IBA 09/2004
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2004
1	MagnesiumIBA 09/2004
1	SaltsIBA 09/2004
1	N-Methylaspartate (NMDA)IBA 09/2004
1	Caspase 3 (Caspase-3)IBA 08/2004
1	Presenilin-1IBA 08/2004
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 08/2004
1	CaspasesIBA 08/2004
1	Peptide Hydrolases (Proteases)FDA Link 05/2004
1	CalciumIBA 05/2004
1	Eosine Yellowish-(YS) (Eosin)IBA 03/2004
1	Hematoxylin (Haematoxylon)IBA 03/2004
1	Amyloid (Amyloid Fibrils)IBA 12/2002
1	Peptides (Polypeptides)IBA 12/2002

Therapy/Procedure

2	Therapeutics 04/2008 - 09/2004
1	Catheters 07/2017
1	Denervation 07/2017
1	Thrombolytic Therapy 08/2009
1	Lasers (Laser) 07/2008